Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Paraguayan researchers develop Artificial Intelligence system that would help predict drug side effects

It is a system that through data would be able to predict side effects or reactions in patients when receiving some type of medication.

Paraguayan researcher Diego Galeano, who is part of the National Investigator Inventive Program (PRONII) of the National Council of Science and Technology (CONACYT) in collaboration with machine learning and artificial intelligence (AI) specialist Alberto Paccanaro, has developed this AI model that predicts the likelihood of predicting reactions or side effects in patients when receiving their treatment.

In September the article: Predicting the Frequency of Drug Side Effectswas published in the journal Nature Communications. “We present a machine learning framework for computationally predicting frequencies of drug side effects. Our matrix decomposition algorithm learns latent signatures of drugs and side effects that are both reproducible and biologically interpretable. We show the usefulness of our approach on 759 structurally and therapeutically diverse drugs and 994 side effects from all human physiological systems. Our approach can be applied to any drug for which a small number of side effect frequencies have been identified, in order to predict the frequencies of further, yet unidentified, side effects.”

The purpose of this novel method is to predict the side effects of medications to avoid risks in patients that may become lethal. Even another problem I could solve is avoiding medicine shortage. In addition to the benefits to end consumers of drugs, this algorithm would save a huge amount of money on pharmaceutical companies' investments to develop new drugs.

Alberto Paccanaro, Professor of Computational Biology at Royal Holloway, University of London, highlighted the relevance of this project: “There are several examples of medicines that had to be withdrawn from the market due to unknown side effects. Our work will help develop safer medicines for patients.”

“Our approach for predicting the frequencies of drug side effects is to use a matrix decomposition algorithm that learns a small set of latent features (or signatures) that encode the biological interplay between drugs and side effects,” they explain in the Discussion section in the article.

The drugs were grouped according to their main anatomical, therapeutic and chemical classes, while side effects were grouped according to their organ and system classification categories in MedDRA (Medical Dictionary for Regulatory Activities).

The machine learning algorithm was designed so that pharmaceutical companies can create more accurate drugs and perhaps in less time, so it is sought to inform that industry first so that they know what are the most recurrent side effects in patients depending on the drugs.

The article published in Nature Communications is available for free at the following link: https://www.nature.com/articles/s41467-020-18305-y#Sec8

Outstanding news

News by country

Share

Digital Health in the world

  • — Science Brief: Omicron (B.1.1.529) Variant/CDC updates
    See more
  • —Coronavirus resource center/Johns Hopkins
    See more
  • — Epidemiological tracing of COVID-19 contacts / Johns Hopkins Course
    See more
  • — SARS-CoV-2 infection behavior / FCS calculator
    See more
  • — Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic/ Article The Lancet
    See more
  • —Genomic Epidemiology Tracker/GISAID
    See more
  • — Mexican Genomic Surveillance Consortium
    See more
Secured By miniOrange